Suite 1300
Salt Lake City, UT 84111
Block-1 3rd Floor, Perungudi Bypass Rd, Perungudi,
Chennai - 600096
MGR Main Rd,
Perungudi, Chennai - 600096
Villupuram,
Tamil Nadu – 605602
Step Therapy Override
Step Therapy Overrides That Get
Patients to the Right Therapy First
Step therapy exception requests built on clinical documentation, medical necessity justification, and payer-specific override pathways — for patients with contraindications, prior treatment failures, or therapeutic urgency that makes step protocols clinically inappropriate.
88%+
Override Approval Rate
< 5 DAY
Median Turnaround
PAYER-SPECIFIC
Pathways
The Reality
Why step therapy has become the hidden tax on specialty pharmacy revenue?
Step Therapy Now Covers Most Specialty Classes
Step therapy protocols now apply to biologics, oral oncolytics, immunology, gastroenterology, rheumatology, hepatology, and most other specialty drug classes. A specialty pharmacy without dedicated override capability faces step delays on the majority of new starts.
Override Pathways Vary by Payer
Each payer runs its own step therapy override protocol — different clinical criteria, different documentation requirements, different escalation paths. CMS Medicare Advantage rules differ from commercial, and managed Medicaid layers state-specific requirements on top.
Clinical Documentation Is the Differentiator
Successful step therapy overrides are not won on argumentation — they are won on documentation. Prior treatment failure records, contraindication evidence, adverse event histories, and clinical urgency justification need to be assembled correctly the first time.
Prescriber Time Is the Bottleneck
Override submissions require prescriber attestation and clinical documentation. Without coordinated prescriber engagement, override packets sit incomplete for days or weeks while patients wait on therapy.
Patient Abandonment Risk
Patients facing step therapy delays often abandon specialty therapy before the override resolves. CMS reports specialty therapy abandonment rates above 35% on first-fill — and step therapy is a leading driver.
CMS 2024 Rule Changes
CMS 2024 Medicare Advantage rules tightened step therapy override requirements and shortened response timelines. Pharmacies running override workflows on pre-2024 protocols face higher denial rates and longer cycle times.
Our approach
We run step therapy override as standing capability, not one-off appeals
AnnexMed runs step therapy override as a dedicated operational discipline — with payer-specific pathway libraries, clinical documentation assembly workflows, and coordinated prescriber engagement protocols. We don’t treat each override as a one-off appeal. We treat the override capability as standing infrastructure that catches step delays before they become patient abandonment.
We serve specialty pharmacies, infusion centers, and home infusion providers where step therapy delays directly impact therapy starts, patient adherence, and revenue capture. Our team manages override submissions across the top 40 commercial plans, Medicare Advantage, managed Medicaid carriers, and state Medicaid programs — with payer-specific clinical criteria and escalation pathways pre-built.
Recent client results
88%+
Step Therapy Override Approval Rate
< 5 days
Median Override
Turnaround
Top 40
Payer Pathways
Pre-Built
How we support you
End-to-End step therapy override operation
Clinical Analysis
Override eligibility evaluation
- Step therapy criteria lookup by payer
- Prior treatment failure documentation review
- Contraindication and adverse event analysis
- Therapeutic urgency clinical assessment
- Comparable agent failure history compilation
- Override pathway selection by payer policy
Packet Assembly
Documentation for approval
- Prior treatment failure records collection
- Lab results and biomarker documentation
- Adverse event and contraindication evidence
- Prescriber attestation letter coordination
- Medical necessity justification per payer criteria
- Patient clinical history compilation
Submission & Escalation
Active pathway management
- Payer-specific override submission
- Status tracking through adjudication
- Peer-to-peer coordination if escalated
- Denial appeals with refined documentation
- External review escalation when appropriate
- Approval notification and therapy start coordination
Financial impact
What step therapy override capability means in dollars?
Fast Results
Built for Modern Step Therapy
Improvement Area
Estimated Annual Impact
Override Approval Rate Improvement (54% → 89%)
$500K – $1.8M annually in newly approved therapy starts
Therapy Abandonment Prevention
$400K – $1.5M annually in retained first-fill revenue
Turnaround Acceleration (12 → 4 days)
$200K – $700K in reduced therapy delay impact
Peer-to-Peer Escalation Capture
$150K – $500K annually in escalated approvals
External Review Recovery
$100K – $400K annually in second-level overturn revenue
Continuing-Patient Step Renewal Protection
$200K – $700K annually in renewal cycle retention
Staffing Cost Reduction / Replacement
$180K – $450K annually
Step therapy override performance targets
Performance Metric
Industry Benchmark
AnnexMed Target
First-Pass Override Approval Rate
Specialty avg: 52–62%
88%+
Median Override Turnaround
Specialty avg: 10–14 days
< 5 days
Therapy Abandonment Rate (Step Therapy)
Specialty avg: 28–38%
< 10%
Peer-to-Peer Conversion Rate
Specialty avg: 42–55%
78%+
External Review Overturn Rate
Industry varies widely
65%+
Payer Pathway Coverage
Most vendors cover 8–15 plans
Top 40 plans
Clinical Documentation Completeness
Industry avg: 72–84%
98%+
CMS 2024 Compliance
Industry: variable adoption
Standard
Why AnnexMed?
In-house override submission Vs. AnnexMed operation
In-House / Traditional
AnnexMed Partnership
Payer Pathway Coverage
Top 5–10 plans, gaps elsewhere
Top 40 commercial, Medicare Advantage, and managed Medicaid pathways
Override Approval Rate
52–62% on first submission
88%+ first-pass approval with payer-tailored documentation
Clinical Documentation
Inconsistent; missing evidence kills approvals
Standardized packet assembly with prior failure and contraindication evidence
Turnaround Time
10–14 days median
Under 5 days median with coordinated prescriber engagement
Peer-to-Peer Coordination
Reactive; many escalations missed
Standard escalation pathway with prescriber preparation packets
External Review Pursuit
Rarely used
Standard pathway for high-value denials
CMS 2024 Adaptation
Many pharmacies still on pre-2024 protocols
Pathway library updated to current CMS Medicare Advantage rules
Cost to Operate
$85K–$120K per FTE for PA + clinical coordinator
30–40% lower with no hiring, attrition, or training overhead
Technology
Powered by proprietary AI & analytics
AnnexMed’s technology stack was built for payer-specific operational demands, not adapted from provider-side billing tools. Risk adjustment accuracy, payment integrity, and credentialing compliance each require different data models, workflow logic, and reporting architectures than provider RCM. Our platform reflects that.
AI Agents & Automation
AI Agents & Intelligent Automation deploys autonomous AI agents across the full revenue cycle, automating eligibility verification, prior authorization, claims processing, payment posting, and denial management at hospital scale and speed.
Data & Analytics Platform
Data & Analytics Platform delivers real-time Power BI dashboards built for hospital executive visibility, including system-wide KPIs, service line performance, payer analysis, productivity, financial forecasting, and national benchmarking insights.
Intelligent AR Management
Intelligent AR Management handles A/R follow-up at hospital scale with intelligent worklists prioritized by dollar value and aging, payer-specific follow-up rules, automated escalation for high-value accounts, and full accountability for every claim.
Computer Assisted Coding
Computer Assisted Coding orchestrates hospital coding operation, intelligent chart assignment by service line, TAT tracking with SLA monitoring, quality audits with accuracy scoring, and coder performance management at enterprise scale.
Together, these platforms create a fully instrumented RCM operation where nothing falls through the cracks. You don’t interact with these systems directly, but the results they enable show up directly in your financial performance.
Ready to stop losing specialty therapy starts to step therapy delays?
Trusted by 100+ Healthcare Providers | AAPC, AHIMA & AAHAM Certified | SOC 2 Type II | HIPAA Compliant
Payer client outcomes
$15M–$40M
Risk
Adjustment
$18M–$50M
Payment
Integrity
6 Weeks
Credentialing Clearance
$15M–$50M+
Revenue
Impact
Case Studies
See the impact we deliver
Discover how AnnexMed reduces denials, accelerates reimbursements, and strengthens financial performance. Backed by measurable outcomes and proven RCM expertise, we deliver operational excellence, revenue stability, and sustainable growth you can trust.
Client Voices
See how our clients succeed
Proven RCM expertise. Delivered at scale.
For over 20 years, AnnexMed has delivered RCM solutions nationwide, combining expert billing, coding, and AR support to drive measurable results and growth.
- 20+ years of proven healthcare RCM experience
- 1,500+ professionals supporting billing, coding & AR
- 500+ certified coders across multiple specialties
- 99%+ compliance with HIPAA and security standards
- All 50 states served with consistent, scalable operations
